HX008 Plus Irinotecan Versus Placebo Plus Irinotecan as Second-line Treatment in Advanced Gastric Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
64 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Anhui Provincial Cancer Hospital
Hefei, Anhui, China
Recruiting - Anhui Provincial Hospital
Hefei, Anhui, China
Recruiting - the Second Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
Recruiting - Beijing Chaoyang Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Recruiting - Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Recruiting - Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
Recruiting - Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Recruiting - Peking University Internationale Hospital
Beijing, Beijing Municipality, China
Recruiting - Peking University Third Hospital
Beijing, Beijing Municipality, China
Recruiting - Chongqing University Cancer Hospital
Chongqing, Chongqing Municipality, China
Recruiting - Fujian Cancer Hospital
Xiamen, Fujian, China
Recruiting - Gansu Wuwei Tumor Hospital
Wuwei, Gansu, China
Recruiting - Affiliated Cancer Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
Not, yet, recruiting - Zhongshan People'S Hospital
Guangzhou, Guangdong, China
Not, yet, recruiting - Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center
Shenzhen, Guangdong, China
Recruiting - Peking University Shenzhen Hospital
Shenzhen, Guangdong, China
Recruiting - Guangxi Medical University Cancer Hospital
Naning, Guangxi, China
Recruiting - the First Affiliated Hospital, Sun Yat-Sen University
Guangzhou, Guangzhou, China
Not, yet, recruiting - Affiliated Hospital of Hebei University
Shijiazhuang, Hebei, China
Recruiting - the First Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
Recruiting - the Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
Recruiting - the Affiliated Cancer Hospital of Harbin Medical University
Harbin, Heilongjiang, China
Recruiting - Henan Cancer Hospital
Zhengzhou, Henan, China
Recruiting - Henan Provincial People'S Hospital
Zhengzhou, Henan, China
Recruiting - the First Affiliated Hospital of Henan Science&technology University
Zhengzhou, Henan, China
Recruiting - the First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Recruiting - Hunan Cancer Hospital
Changsha, Hunan, China
Recruiting - the Second Xiangya Hospital of Cancer South University
Changsha, Hunan, China
Recruiting - Xiangya Hospital, Central South University
Changsha, Hunan, China
Not, yet, recruiting - the Affiliated People'S Hospital of Inner Mongolia Medical University
Hohhot, Inner Mongolia, China
Recruiting - Changzhou Cancer Hospital
Changzhou, Jiangsu, China
Recruiting - Jiangsu Provincial Hospital
Nanjing, Jiangsu, China
Recruiting - Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China
Recruiting - Zhongda Hospital Southeast Universtiy
Nanjing, Jiangsu, China
Not, yet, recruiting - Nantong Tumor Hospital
Nantong, Jiangsu, China
Recruiting - the Second Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
Recruiting - Xuzhou Central Hospital
Xuzhou, Jiangsu, China
Recruiting - Yangzhou First People'S Hospital
Yangzhou, Jiangsu, China
Recruiting - Jiangxi Cancer Hospital
Nanchang, Jiangxi, China
Recruiting - the First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Sept 2020
- Primary completion
- 10 Aug 2023
- Completion
- 10 Aug 2023
- Last update posted
- 28 Jan 2021
- Registered enrollment
- 560
- Registry id
- NCT04486651
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.